Skip to main content
. Author manuscript; available in PMC: 2015 Apr 15.
Published in final edited form as: Int J Cancer. 2013 Oct 18;134(8):1889–1898. doi: 10.1002/ijc.28509

Table 3.

Comparison of type-specific oncogenic HPVa viral load in incident, redetected and prevalent infections

Log10 viral loadb (Mean
± SD)		 p-valuec
Prevalentd (n=286) 2.1 ± 2.2 0.0921
Incidentd (n=142) 1.8 ± 2.0
Incidentd (n=142) 1.8 ± 2.0 0.0002
Redetectede (n=30) 0.9 ± 0.9
a

Includes types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73, 82 (type 53 was excluded from all viral load analyses).

b

per nanogram of cellular DNA.

c

P-value for mean difference in viral load, adjusted for HPV type.

d

Measured at time of 1st type-specific positive by the Roche assay.

e

Measured at time of 1st redetection by the Roche assay for type-specific infections with intercurrent negatives (following either prevalent or incident detection).